NASDAQ:ESPR - Esperion Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$41.39 -2.84 (-6.42 %)
(As of 03/24/2019 03:08 PM ET)
Previous Close$41.39
Today's Range$41.36 - $44.39
52-Week Range$33.06 - $79.30
Volume514,203 shs
Average Volume620,574 shs
Market Capitalization$1.11 billion
P/E Ratio-5.49
Dividend YieldN/A

Analyst Ratings

Esperion Therapeutics (NASDAQ:ESPR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
13 Wall Street analysts have issued ratings and price targets for Esperion Therapeutics in the last 12 months. Their average twelve-month price target is $74.9167, suggesting that the stock has a possible upside of 81.00%. The high price target for ESPR is $114.00 and the low price target for ESPR is $45.00. There are currently 2 sell ratings, 2 hold ratings, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.622.572.572.58
Ratings Breakdown: 2 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
1 Strong Buy Rating(s)
3 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
3 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
2 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $74.9167$79.1154$76.6071$83.2917
Price Target Upside: 81.00% upside83.05% upside38.98% upside72.38% upside

Esperion Therapeutics (NASDAQ:ESPR) Consensus Price Target History

Price Target History for Esperion Therapeutics (NASDAQ:ESPR)

Esperion Therapeutics (NASDAQ:ESPR) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/14/2019Chardan CapitalReiterated RatingHold$50.00MediumView Rating Details
3/13/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$38.00 ➝ $47.00HighView Rating Details
3/1/2019Northland SecuritiesReiterated RatingBuy$65.00LowView Rating Details
1/15/2019CowenReiterated RatingBuy$94.00LowView Rating Details
1/7/2019Needham & Company LLCBoost Price TargetStrong-Buy$94.00 ➝ $114.00LowView Rating Details
12/13/2018Goldman Sachs GroupInitiated CoverageSell ➝ Sell$45.00HighView Rating Details
12/10/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$89.00 ➝ $104.00MediumView Rating Details
10/16/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$82.00HighView Rating Details
8/17/2018CitigroupUpgradeNeutral ➝ Buy$57.00 ➝ $75.00LowView Rating Details
5/16/2018UBS GroupSet Price TargetBuy$90.00 ➝ $75.00LowView Rating Details
5/4/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$108.00 ➝ $73.00N/AView Rating Details
5/3/2018Deutsche BankLower Price TargetBuy ➝ Buy$100.00 ➝ $75.00HighView Rating Details
5/2/2018Bank of AmericaReiterated RatingBuy ➝ UnderperformHighView Rating Details
3/8/2018JMP SecuritiesBoost Price TargetOutperform$60.00 ➝ $153.00HighView Rating Details
8/21/2017Jefferies Financial GroupReiterated RatingBuy$85.00LowView Rating Details
(Data available from 3/24/2017 forward)
This page was last updated on 3/24/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel